Model Medicines announced it raised $950,000 in an initial filing from an offering of $2 Million

Company

Location

About

Model Medicines is an AI-driven human health company using advanced technology to model the full complexity of chemistry and human biology, accelerating the creation of life-changing drugs. Founded in 2019 to fulfill the promise of AI-driven drug discovery, the company has validated 67 assets in cellular disease models across 12 therapeutic targets spanning multiple biological areas. With a robust pipeline of patent-pending therapeutics in oncology, virology, gastric disorders, neurological disorders, and weight disorders, Model Medicines is driving innovation at the intersection of data science, biology, and drug development.